198 related articles for article (PubMed ID: 9014009)
21. Characterization of murine monoclonal antibodies directed against the submembrane protein p17 of HIV-1.
Niedrig M; Harthus HP; Bröker M; Meloen R; Gelderblom H; Pauli G
Hybridoma; 1993 Aug; 12(4):431-9. PubMed ID: 7503941
[TBL] [Abstract][Full Text] [Related]
22. Analysis of the anti-HIV-1 activity of an anti-p17-derivative peptide (P30-52) monoclonal antibody.
Ota A; Ueda S
Hybridoma; 1999 Aug; 18(4):305-14. PubMed ID: 10571260
[TBL] [Abstract][Full Text] [Related]
23. [Expression and characterization of HIV-1 Gag p17-p24 protein].
Li TY; Jin NY; Wang HW; Guo ZR; Fang HH; An RG; Yin Z
Sheng Wu Gong Cheng Xue Bao; 2000 Jan; 16(1):65-8. PubMed ID: 10883279
[TBL] [Abstract][Full Text] [Related]
24. Decline in CTL and antibody responses to HIV-1 p17 and p24 antigens in HIV-1-infected hemophiliacs irrespective of disease progression. A 5-year follow-up study.
O'Toole CM; Lowdell MW; Chargelegue D; Colvin BT
AIDS Res Hum Retroviruses; 1992 Aug; 8(8):1361-8. PubMed ID: 1281655
[TBL] [Abstract][Full Text] [Related]
25. Earlier detection of human immunodeficiency virus type 1 p24 antigen and immunoglobulin G and M antibodies to p17 antigen in seroconversion serum panels by immune complex transfer enzyme immunoassays.
Hashida S; Ishikawa S; Hashinaka K; Nishikata I; Oka S; Ishikawa E
Clin Diagn Lab Immunol; 2000 Nov; 7(6):872-81. PubMed ID: 11063490
[TBL] [Abstract][Full Text] [Related]
26. HIV-1 gag proteins in virions and in infected cell fractions.
Sharova NK; Grigor'ev VB; Bukrinskaya AG
Biomed Sci; 1991; 2(3):279-84. PubMed ID: 1751761
[TBL] [Abstract][Full Text] [Related]
27. Gag-derived proteins of HIV-1 isolates from Indian patients: cloning, expression, and purification of p17 of B- and C-subtypes.
Gupta S; Arora K; Gupta A; Chaudhary VK
Protein Expr Purif; 2001 Apr; 21(3):378-85. PubMed ID: 11281711
[TBL] [Abstract][Full Text] [Related]
28. Use of the presence of anti-protein gag antibodies as an evolution marker of HIV infection.
Neguţ EA; Usein CR; Sfartz S; Zugun-Eloae F
Roum Arch Microbiol Immunol; 1999; 58(2):131-46. PubMed ID: 11845452
[TBL] [Abstract][Full Text] [Related]
29. Binding of antibodies to virion-associated gp120 molecules of primary-like human immunodeficiency virus type 1 (HIV-1) isolates: effect on HIV-1 infection of macrophages and peripheral blood mononuclear cells.
Stamatatos L; Zolla-Pazner S; Gorny MK; Cheng-Mayer C
Virology; 1997 Mar; 229(2):360-9. PubMed ID: 9126249
[TBL] [Abstract][Full Text] [Related]
30. Recognition of two overlapping CTL epitopes in HIV-1 p17 by CTL from a long-term nonprogressing HIV-1-infected individual.
Harrer T; Harrer E; Barbosa P; Kaufmann F; Wagner R; Brüggemann S; Kalden JR; Feinberg M; Johnson RP; Buchbinder S; Walker BD
J Immunol; 1998 Nov; 161(9):4875-81. PubMed ID: 9794421
[TBL] [Abstract][Full Text] [Related]
31. Sensitive enzyme immunoassay of antibodies to HIV-1 p17 antigen using indirectly immobilized recombinant p17 for diagnosis of HIV-1 infection.
Ishikawa S; Hashinaka K; Hashida S; Oka S; Ishikawa E
J Clin Lab Anal; 1998; 12(6):343-50. PubMed ID: 9850185
[TBL] [Abstract][Full Text] [Related]
32. Passage of HIV-1 molecular clones into different cell lines confers differential sensitivity to neutralization.
Zhang YJ; Fredriksson R; McKeating JA; Fenyö EM
Virology; 1997 Nov; 238(2):254-64. PubMed ID: 9400598
[TBL] [Abstract][Full Text] [Related]
33. Inhibitory mechanism of anti-P30-52 monoclonal antibody against human immunodeficiency virus type 1 (HIV-1) multiplication in infected MT-4 cells.
Ota A; Ueda S
Hybridoma; 1999 Jun; 18(3):235-41. PubMed ID: 10475237
[TBL] [Abstract][Full Text] [Related]
34. A 7-year analysis of anti-Gag (p17 and p24) antibodies in HIV-1-seropositive patients with haemophilia: immunoglobulin G titre and avidity are early predictors of clinical course.
Chargelegue D; Colvin BT; O'Toole CM
AIDS; 1993 Nov; 7 Suppl 2():S87-90. PubMed ID: 7909231
[TBL] [Abstract][Full Text] [Related]
35. Pairwise decomposition of residue interaction energies of single chain Fv with HIV-1 p17 epitope variants.
Lee VS; Tue-ngeun P; Nangola S; Kitidee K; Jitonnom J; Nimmanpipug P; Jiranusornkul S; Tayapiwatana C
Mol Immunol; 2010 Feb; 47(5):982-90. PubMed ID: 20022377
[TBL] [Abstract][Full Text] [Related]
36. A longitudinal study of the IgG antibody response to HIV-1 p17 gag protein in HIV-1+ patients with haemophilia: titre and avidity.
Chargelegue D; O'Toole CM; Colvin BT
Clin Exp Immunol; 1993 Sep; 93(3):331-6. PubMed ID: 8370162
[TBL] [Abstract][Full Text] [Related]
37. Vaccine-induced HIV seropositivity: a problem on the rise.
Van Braeckel E; Koutsoukos M; Bourguignon P; Clement F; McNally L; Leroux-Roels G
J Clin Virol; 2011 Apr; 50(4):334-7. PubMed ID: 21300566
[TBL] [Abstract][Full Text] [Related]
38. Frequency of class I HLA-restricted anti-HIV CD8+ T cells in individuals receiving highly active antiretroviral therapy (HAART).
Gray CM; Lawrence J; Schapiro JM; Altman JD; Winters MA; Crompton M; Loi M; Kundu SK; Davis MM; Merigan TC
J Immunol; 1999 Feb; 162(3):1780-8. PubMed ID: 9973442
[TBL] [Abstract][Full Text] [Related]
39. Neutralization of human immunodeficiency virus type 1 (HIV-1) mediated by parotid IgA of HIV-1-infected patients.
Moja P; Tranchat C; Tchou I; Pozzetto B; Lucht F; Desgranges C; Genin C
J Infect Dis; 2000 May; 181(5):1607-13. PubMed ID: 10823760
[TBL] [Abstract][Full Text] [Related]
40. Effect of epitope position on neutralization by anti-human immunodeficiency virus monoclonal antibody 2F5.
Ou W; Lu N; Yu SS; Silver J
J Virol; 2006 Mar; 80(5):2539-47. PubMed ID: 16474160
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
